CLINICAL_TRIALS
trial_result
· 2010-02-23
Clinical Trial Update: RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag [Phase 3]
Summary
Phase 3 randomized, placebo-controlled trial of eltrombopag in idiopathic immune thrombocytopenia completed. Results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopaenic, Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2010-02-23